ScanSource Delivers Outstanding First Quarter Performance
ScanSource, Inc. (NASDAQ: SCSC) reported a strong financial performance for the first quarter of fiscal year 2023, ending September 30, 2022. Net sales reached $943.8 million, marking a 10.1% year-over-year increase. Gross profit rose to $113.5 million, up 11.7%, with a gross profit margin of 12.02%. GAAP net income was $24.0 million ($0.94 per share), an 8.9% increase from the prior year. The company affirmed its FY23 guidance, projecting at least 5.5% net sales growth and adjusted EBITDA of at least $174 million, demonstrating robust demand and effective channel partnerships.
- Net sales increased by 10.1% to $943.8 million.
- Gross profit rose 11.7% to $113.5 million.
- GAAP net income grew 8.9% to $24.0 million, with diluted EPS at $0.94.
- Operating income increased 15.0% to $34.9 million.
- The company reaffirmed annual guidance for FY23, expecting at least 5.5% net sales growth.
- Adjusted return on invested capital decreased to 15.6% from 17.5% year-over-year.
|
First Quarter Summary |
|||||||||
|
Q1 FY23 |
|
Q1 FY22 |
|
Change |
|||||
|
(in thousands, except per share data) |
|||||||||
Select reported measures: |
|
|
|
|
|
|||||
Net sales |
$ |
943,813 |
|
|
$ |
857,583 |
|
|
10.1 |
% |
Gross profit |
$ |
113,485 |
|
|
$ |
101,572 |
|
|
11.7 |
% |
Gross profit margin % |
|
12.02 |
% |
|
|
11.84 |
% |
|
18bp |
|
Operating income |
$ |
34,888 |
|
|
$ |
30,328 |
|
|
15.0 |
% |
GAAP net income |
$ |
24,042 |
|
|
$ |
22,073 |
|
|
8.9 |
% |
GAAP diluted EPS |
$ |
0.94 |
|
|
$ |
0.86 |
|
|
9.3 |
% |
Select Non-GAAP measures: |
|
|
|
|
|
|||||
Adjusted EBITDA |
$ |
45,275 |
|
|
$ |
41,394 |
|
|
9.4 |
% |
Adjusted EBITDA margin % |
|
4.80 |
% |
|
|
4.83 |
% |
|
-3bp |
|
Non-GAAP net income |
$ |
27,203 |
|
|
$ |
25,550 |
|
|
6.5 |
% |
Non-GAAP diluted EPS |
$ |
1.07 |
|
|
$ |
0.99 |
|
|
8.1 |
% |
"We had an outstanding start to our fiscal year, delivering
Quarterly Results
Net sales for the first quarter of fiscal year 2023 totaled
Gross profit for the first quarter of fiscal year 2023 totaled
For the first quarter of fiscal year 2023, operating income increased to
On a GAAP basis, net income for the first quarter of fiscal year 2023 totaled
Adjusted EBITDA for the first quarter of fiscal year 2023 increased
Annual Financial Outlook for Fiscal Year 2023
|
|
FY23 Annual Outlook |
|
|
|
Net sales growth, year-over-year |
|
At least |
Adjusted EBITDA (non-GAAP) |
|
At least |
Adjusted EBITDA is a non-GAAP measure, which excludes estimates for amortization of intangible assets, depreciation expense, and non-cash share-based compensation expense. ScanSource’s outlook does not include the potential impact of any business combinations, asset acquisitions, divestitures, strategic investments, or other significant transactions that may be completed after the date hereof. These statements are forward-looking, and actual results may differ materially.
Webcast Details and Earnings Infographic
At approximately
Safe Harbor Statement
This press release contains “forward-looking” statements, including the Company's FY23 outlook, which involve risks and uncertainties. Any number of factors could cause actual results to differ materially from anticipated results, including, but not limited to, failure to hire and retain quality employees, risk to the Company's business from a cyber-security attack, supply chain challenges, the failure to manage and implement the Company's organic growth strategy, economic weakness and inflation, a failure of the Company's IT systems, a failure to acquire new businesses, changes in interest and exchange rates and regulatory regimes impacting the Company's international operations, credit risks involving the Company's larger customers and suppliers, loss of the Company's major customers, termination of the Company's relationship with key suppliers or a significant modification of the terms under which it operates with a key supplier, changes in the Company's operating strategy, and other factors set forth in the "Risk Factors" contained in the Company's annual report on Form 10-K for the year ended
Non-GAAP Financial Information
In addition to disclosing results that are determined in accordance with United States Generally Accepted Accounting Principles ("GAAP"), the Company also discloses certain non-GAAP financial measures, which are summarized below. Non-GAAP financial measures are used to understand and evaluate performance, including comparisons from period to period. Non-GAAP results exclude amortization of intangible assets related to acquisitions, change in fair value of contingent consideration, acquisition costs, restructuring costs and other non-GAAP adjustments.
Net sales on a constant currency basis, excluding acquisitions (organic growth): The Company discloses the percentage change in net sales excluding the translation impact from changes in foreign currency exchange rates between reporting periods and excluding the net sales from acquisitions prior to the first full year from the acquisition date. This measure enhances the comparability between periods to help analyze underlying trends on an organic basis.
Additional Non-GAAP Metrics: To evaluate current period performance on a more consistent basis with prior periods, the Company discloses non-GAAP SG&A expenses, non-GAAP operating income, non-GAAP net income and non-GAAP diluted earnings per share (non-GAAP diluted "EPS"). Non-GAAP results exclude amortization of intangible assets related to acquisitions, changes in fair value of contingent consideration, acquisition and divestiture costs, impairment charges, restructuring costs, and other non-GAAP adjustments. These year-over-year metrics include the translation impact of changes in foreign currency exchange rates. Non-GAAP metrics are useful in assessing and understanding the Company's operating performance, especially when comparing results with previous periods or forecasting performance for future periods.
Adjusted earnings before interest expense, income taxes, depreciation, and amortization (“Adjusted EBITDA”): Adjusted EBITDA starts with net income and adds back interest expense, income tax expense, depreciation expense, amortization of intangible assets, changes in fair value of contingent considerations, and other non-GAAP adjustments, including acquisition and divestiture costs, impairment charges, restructuring costs and non-cash share-based compensation expense. Since Adjusted EBITDA excludes some non-cash costs of investing in our business and people, management believes that Adjusted EBITDA shows the profitability from our business operations more clearly. The presentation for Adjusted EBITDA for all periods presented has been recast to reflect this change to enhance comparability between periods.
Adjusted return on invested capital ("Adjusted ROIC"): Adjusted ROIC assists management in comparing the Company's performance over various reporting periods on a consistent basis because it removes from our operating results the impact of items that do not reflect our core operating performance. We believe the calculation of Adjusted ROIC provides useful information to investors and is an additional relevant comparison of our performance. Adjusted ROIC is calculated as Adjusted EBITDA over invested capital. Invested capital is defined as average equity plus average daily funded interest-bearing debt for the period. Management believes the calculation of Adjusted ROIC provides useful information to investors and is an additional relevant comparison of the Company's performance during the year.
These non-GAAP financial measures have limitations as analytical tools, and the non-GAAP financial measures that the Company reports may not be comparable to similarly titled amounts reported by other companies. Analysis of results and outlook on a non-GAAP basis should be considered in addition to, and not in substitution for or as superior to, measurements of financial performance prepared in accordance with GAAP. A reconciliation of the Company's non-GAAP financial information to GAAP is set forth in the Supplementary Information (Unaudited) below.
About
|
|||||||
Condensed Consolidated Balance Sheets (Unaudited) |
|||||||
(in thousands) |
|||||||
|
|
|
|
||||
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
40,472 |
|
|
$ |
37,987 |
|
Accounts receivable, less allowance of
and |
|
744,946 |
|
|
|
729,442 |
|
Inventories |
|
675,798 |
|
|
|
614,814 |
|
Prepaid expenses and other current assets |
|
126,484 |
|
|
|
141,562 |
|
Total current assets |
|
1,587,700 |
|
|
|
1,523,805 |
|
Property and equipment, net |
|
36,853 |
|
|
|
37,477 |
|
|
|
211,736 |
|
|
|
214,435 |
|
Identifiable intangible assets, net |
|
78,724 |
|
|
|
84,427 |
|
Deferred income taxes |
|
13,381 |
|
|
|
15,668 |
|
Other non-current assets |
|
71,918 |
|
|
|
61,616 |
|
Total assets |
$ |
2,000,312 |
|
|
$ |
1,937,428 |
|
Liabilities and Shareholders’ Equity |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
710,919 |
|
|
$ |
714,177 |
|
Accrued expenses and other current liabilities |
|
73,760 |
|
|
|
88,455 |
|
Income taxes payable |
|
5,274 |
|
|
|
34 |
|
Current portion of long-term debt |
|
4,102 |
|
|
|
11,598 |
|
Total current liabilities |
|
794,055 |
|
|
|
814,264 |
|
Deferred income taxes |
|
2,882 |
|
|
|
3,144 |
|
Long-term debt, net of current portion |
|
149,631 |
|
|
|
123,733 |
|
Borrowings under revolving credit facility |
|
172,702 |
|
|
|
135,839 |
|
Other long-term liabilities |
|
54,038 |
|
|
|
53,920 |
|
Total liabilities |
|
1,173,308 |
|
|
|
1,130,900 |
|
Commitments and contingencies |
|
|
|
||||
Shareholders’ equity: |
|
|
|
||||
Preferred stock, no par value; 3,000,000 shares authorized, none issued |
|
— |
|
|
|
— |
|
Common stock, no par value; 45,000,000 shares authorized, 25,225,902 and 25,187,351 shares issued and outstanding at |
|
66,069 |
|
|
|
64,297 |
|
Retained earnings |
|
870,911 |
|
|
|
846,869 |
|
Accumulated other comprehensive loss |
|
(109,976 |
) |
|
|
(104,638 |
) |
Total shareholders’ equity |
|
827,004 |
|
|
|
806,528 |
|
Total liabilities and shareholders’ equity |
$ |
2,000,312 |
|
|
$ |
1,937,428 |
|
*Derived from audited financial statements. |
|
|||||||
Condensed Consolidated Income Statements (Unaudited) |
|||||||
(in thousands, except per share data) |
|||||||
|
|
|
|
||||
|
Quarter ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
Net sales |
$ |
943,813 |
|
|
$ |
857,583 |
|
Cost of goods sold |
|
830,328 |
|
|
|
756,011 |
|
Gross profit |
|
113,485 |
|
|
|
101,572 |
|
Selling, general and administrative expenses |
|
71,593 |
|
|
|
63,854 |
|
Depreciation expense |
|
2,763 |
|
|
|
2,880 |
|
Intangible amortization expense |
|
4,241 |
|
|
|
4,510 |
|
Operating income |
|
34,888 |
|
|
|
30,328 |
|
Interest expense |
|
3,448 |
|
|
|
1,660 |
|
Interest income |
|
(1,589 |
) |
|
|
(1,026 |
) |
Other expense, net |
|
746 |
|
|
|
263 |
|
Income before income taxes |
|
32,283 |
|
|
|
29,431 |
|
Provision for income taxes |
|
8,241 |
|
|
|
7,358 |
|
Net income |
$ |
24,042 |
|
|
$ |
22,073 |
|
|
|
|
|
||||
Per share data: |
|
|
|
||||
Net income per common share, basic |
$ |
0.95 |
|
|
$ |
0.87 |
|
Weighted-average shares outstanding, basic |
|
25,201 |
|
|
|
25,512 |
|
|
|
|
|
||||
Net income per common share, diluted |
$ |
0.94 |
|
|
$ |
0.86 |
|
Weighted-average shares outstanding, diluted |
|
25,451 |
|
|
|
25,696 |
|
|
|||||||
Condensed Consolidated Statements of Cash Flows (Unaudited) |
|||||||
(in thousands) |
|||||||
|
Quarter ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
Cash flows from operating activities: |
|
|
|
||||
Net income |
$ |
24,042 |
|
|
$ |
22,073 |
|
Adjustments to reconcile net income to net cash used in operating activities: |
|
|
|
||||
Depreciation and amortization |
|
7,228 |
|
|
|
7,650 |
|
Amortization of debt issue costs |
|
289 |
|
|
|
104 |
|
Provision for doubtful accounts |
|
125 |
|
|
|
(1,027 |
) |
Share-based compensation |
|
2,316 |
|
|
|
2,570 |
|
Deferred income taxes |
|
2,274 |
|
|
|
(183 |
) |
Finance lease interest |
|
2 |
|
|
|
17 |
|
Changes in operating assets and liabilities, net of acquisitions: |
|
|
|
||||
Accounts receivable |
|
(18,799 |
) |
|
|
(26,714 |
) |
Inventories |
|
(62,192 |
) |
|
|
(25,879 |
) |
Prepaid expenses and other assets |
|
14,690 |
|
|
|
(1,174 |
) |
Other non-current assets |
|
(9,469 |
) |
|
|
691 |
|
Accounts payable |
|
(1,053 |
) |
|
|
(26,962 |
) |
Accrued expenses and other liabilities |
|
(13,168 |
) |
|
|
(14,683 |
) |
Income taxes payable |
|
5,256 |
|
|
|
6,558 |
|
Net cash used in operating activities |
|
(48,459 |
) |
|
|
(56,959 |
) |
Cash flows from investing activities: |
|
|
|
||||
Capital expenditures |
|
(1,758 |
) |
|
|
(1,090 |
) |
Net cash used in investing activities |
|
(1,758 |
) |
|
|
(1,090 |
) |
Cash flows from financing activities: |
|
|
|
||||
Borrowings on revolving credit, net of expenses |
|
579,011 |
|
|
|
526,637 |
|
Repayments on revolving credit, net of expenses |
|
(542,147 |
) |
|
|
(470,237 |
) |
Borrowings on long-term debt, net |
|
18,402 |
|
|
|
(2,218 |
) |
Finance lease obligations |
|
771 |
|
|
|
(316 |
) |
Debt issuance costs |
|
(1,407 |
) |
|
|
— |
|
Exercise of stock options |
|
10 |
|
|
|
994 |
|
Taxes paid on settlement of equity awards |
|
(596 |
) |
|
|
— |
|
Net cash provided by financing activities |
|
54,044 |
|
|
|
54,860 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
(1,342 |
) |
|
|
(4,038 |
) |
Increase (decrease) in cash and cash equivalents |
|
2,485 |
|
|
|
(7,227 |
) |
Cash and cash equivalents at beginning of period |
|
37,987 |
|
|
|
62,718 |
|
Cash and cash equivalents at period end |
$ |
40,472 |
|
|
$ |
55,491 |
|
|
|||||||
Supplementary Information (Unaudited) |
|||||||
(in thousands, except percentages) |
|||||||
|
|
|
|
||||
Non-GAAP Financial Information: |
|||||||
|
Quarter ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
Adjusted return on invested capital ratio (Adjusted ROIC), annualized(a) |
|
15.6 |
% |
|
|
17.5 |
% |
|
|
|
|
||||
Reconciliation of Net Income to Adjusted EBITDA: |
|
|
|
||||
Net income (GAAP) |
$ |
24,042 |
|
|
$ |
22,073 |
|
Plus: Interest expense |
|
3,448 |
|
|
|
1,660 |
|
Plus: Income taxes |
|
8,241 |
|
|
|
7,358 |
|
Plus: Depreciation and amortization |
|
7,228 |
|
|
|
7,650 |
|
EBITDA (non-GAAP) |
|
42,959 |
|
|
|
38,741 |
|
Plus: Share-based compensation |
|
2,316 |
|
|
|
2,570 |
|
Plus: Acquisition and divestiture costs(b) |
|
— |
|
|
|
83 |
|
Adjusted EBITDA (numerator for Adjusted ROIC) (non-GAAP) |
$ |
45,275 |
|
|
$ |
41,394 |
|
|
|
|
|
||||
Invested Capital Calculations: |
|
|
|
||||
Equity – beginning of the quarter |
$ |
806,528 |
|
|
$ |
731,191 |
|
Equity – end of the quarter |
|
827,004 |
|
|
|
746,094 |
|
Plus: Share-based compensation, net |
|
1,718 |
|
|
|
1,922 |
|
Plus: Acquisition and divestiture costs(b) |
|
— |
|
|
|
83 |
|
Average equity |
|
817,625 |
|
|
|
739,645 |
|
Average funded debt (c) |
|
336,428 |
|
|
|
197,406 |
|
Invested capital (denominator for Adjusted ROIC) (non-GAAP) |
$ |
1,154,053 |
|
|
$ |
937,051 |
|
|
|
|
|
||||
(a) The annualized adjusted EBITDA amount is divided by days in the quarter times 365 days per year, or 366 days for |
|||||||
(b) Acquisition and divestiture costs are generally nondeductible for tax purposes. |
|||||||
(c) Average funded debt is calculated as the average daily amounts outstanding on short-term and long-term interest-bearing debt. |
|
||||||||
Supplementary Information (Unaudited) |
||||||||
|
|
|
|
|||||
|
|
|
|
|||||
|
Quarter ended |
|
|
|||||
|
|
2022 |
|
|
2021 |
|
% Change |
|
Specialty Technology Solutions: |
(in thousands) |
|
|
|||||
Net sales, reported |
$ |
576,329 |
|
$ |
501,711 |
|
14.9 |
% |
Foreign exchange impact (a) |
|
60 |
|
|
— |
|
|
|
Non-GAAP net sales, constant currency |
$ |
576,389 |
|
$ |
501,711 |
|
14.9 |
% |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
Net sales, reported |
$ |
367,484 |
|
$ |
355,872 |
|
3.3 |
% |
Foreign exchange impact (a) |
|
613 |
|
|
— |
|
|
|
Non-GAAP net sales, constant currency |
$ |
368,097 |
|
$ |
355,872 |
|
3.4 |
% |
|
|
|
|
|
|
|||
Consolidated: |
|
|
|
|
|
|||
Net sales, reported |
$ |
943,813 |
|
$ |
857,583 |
|
10.1 |
% |
Foreign exchange impact (a) |
|
673 |
|
|
— |
|
|
|
Non-GAAP net sales, constant currency |
$ |
944,486 |
|
$ |
857,583 |
|
10.1 |
% |
|
|
|
|
|
|
|||
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended |
|
||||||||
Supplementary Information (Unaudited) |
||||||||
|
|
|
|
|
|
|||
|
|
|
|
|||||
|
Quarter ended |
|
|
|||||
|
|
2022 |
|
|
2021 |
|
% Change |
|
|
(in thousands) |
|
|
|||||
Net sales, as reported |
$ |
859,538 |
|
$ |
769,771 |
|
11.7 |
% |
|
|
|
|
|
|
|||
International: |
|
|
|
|
|
|||
Net sales, reported |
$ |
84,275 |
|
$ |
87,812 |
|
(4.0 |
) % |
Foreign exchange impact(a) |
|
673 |
|
|
— |
|
|
|
Non-GAAP net sales, constant currency |
$ |
84,948 |
|
$ |
87,812 |
|
(3.3 |
) % |
|
|
|
|
|
|
|||
Consolidated: |
|
|
|
|
|
|||
Net sales, reported |
$ |
943,813 |
|
$ |
857,583 |
|
10.1 |
% |
Foreign exchange impact(a) |
|
673 |
|
|
— |
|
|
|
Non-GAAP net sales, constant currency |
$ |
944,486 |
|
$ |
857,583 |
|
10.1 |
% |
|
|
|
|
|
|
|||
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended |
Quarter ended |
||||||||||||
|
GAAP Measure |
|
Intangible amortization expense |
|
Acquisition and divestiture costs |
|
Non-GAAP measure |
|||||
|
(in thousands, except per share data) |
|||||||||||
SG&A expenses |
$ |
71,593 |
|
|
— |
|
|
— |
|
|
$ |
71,593 |
Operating income |
|
34,888 |
|
|
4,241 |
|
|
— |
|
|
|
39,129 |
Net income |
|
24,042 |
|
|
3,161 |
|
|
— |
|
|
|
27,203 |
Diluted EPS |
$ |
0.94 |
|
$ |
0.12 |
|
|
— |
|
|
$ |
1.07 |
|
|
|
|
|
|
|
|
|||||
|
Quarter ended |
|||||||||||
|
GAAP Measure |
|
Intangible amortization expense |
|
Acquisition and divestiture costs |
|
Non-GAAP measure |
|||||
|
(in thousands, except per share data) |
|||||||||||
SG&A expense |
$ |
63,854 |
|
|
— |
|
$ |
(83 |
) |
|
$ |
63,771 |
Operating income |
|
30,328 |
|
|
4,510 |
|
|
83 |
|
|
|
34,921 |
Net income |
|
22,073 |
|
|
3,394 |
|
|
83 |
|
|
|
25,550 |
Diluted EPS |
$ |
0.86 |
|
$ |
0.13 |
|
|
— |
|
|
$ |
0.99 |
|
|
|
|
|
|
|
|
|
||||
Supplementary Forward-Looking Information (Unaudited) |
||||
|
|
|
|
|
Annual Financial Outlook for Fiscal Year 2023: |
|
|
||
|
|
|
|
|
|
|
|
FY23 Outlook |
|
GAAP, Operating income |
|
At least |
||
Intangible amortization |
|
|
||
Depreciation expense |
|
|
||
Share-based compensation expense |
|
|
||
Interest income and other income (expense), net |
|
|
|
|
Adjusted EBITDA (non-GAAP) |
|
At least |
||
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20221108005307/en/
Senior EVP, Chief Financial Officer
(864) 286-4302
SVP, Treasurer and Investor Relations
(864) 286-4892
Source:
FAQ
What were the net sales for ScanSource in Q1 FY23?
How much did ScanSource's gross profit increase in Q1 FY23?
What is the diluted EPS reported by ScanSource for Q1 FY23?